Skip to main content
SpringerLink
Log in

Psychiatrische Auffälligkeiten bei Patienten mit Multipler Sklerose

Psychiatric problems in patients with Multiple sclerosis

  • Übersicht
  • Published:
Psychiatrie und Psychotherapie

Zusammenfassung

MS als eine der häufigsten neurologischen Erkrankungen bringt eine Reihe von neuropsychiatrischen Problemen mit sich. In erster Linie wird in der Literatur von affektiven Störungen-Major Depression, bipolaren Störungen, Apathie und Euphorie, aber auch von Angsterkrankungen, Persönlichkeitsstörungen, pathologischem Lachen und Weinen und in seltenen Fällen Psychosen berichtet. Die krankheitsimmanente psychiatrische Symptomatik wird oft übersehen und nicht behandelt. Eine ganzheitliche Sichtweise der Erkrankung, sowie eine entsprechende Behandlung kann die Lebensqualität der Patienten entscheidend verbessern.

Summary

MS as a common neurological disease also implicates a number of neuropsychiatric problems. Depression is the most frequent symptom but there is also evidence about high rates of manic-depressive disorder, apathy, euphoria as well as anxiety, personality disorder, pathological laughing and crying and in rare cases psychosis. These manifestations are often underdiagnosed and not treated. It is important to recognize these associated psychopathological syndromes and to initiate individualized treatment, which can significantly improve quality of life of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

LITERATUR

  • Avasarala JR, Cross AH, Trinkaus K (2003) Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis. Mult Scler 9: 307–310

    Article  PubMed  Google Scholar 

  • Boerner RJ, Kapfhammer HP (1999) Psychopathological changes and cognitive impairment in encephalomyelitis disseminata. Eur Arch Psychiatry Clin Neurosci 249: 96–102

    Article  PubMed  CAS  Google Scholar 

  • Bronnum-Hansen H, Stenager E, Nylev Stenager E, Koch-Henriksen N (2005) Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 76: 1457–1459

    Article  PubMed  CAS  Google Scholar 

  • Brown ES, Chamberlain W, Dhanani N, Paranjpe P, Carmody TJ, Sargeant M (2004) An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J Affect Disord 83: 277–281

    Article  PubMed  CAS  Google Scholar 

  • Browning WN (1990) Exacerbation of symptoms of multiple sclerosis in a patient taking fluoxetine. Am J Psychiatry 147: 1089

    PubMed  CAS  Google Scholar 

  • Calabrese P (2006) Neuropsychology of multiple sclerosis An overview. J Neurol 253 (Suppl 1): i10–i15

    Article  PubMed  Google Scholar 

  • Chwastiak LA, Gibbons LE, Ehde DM, Sullivan M, Bowen JD, Bombardier CH, Kraft GH (2005) Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res 59: 291–298

    Article  PubMed  Google Scholar 

  • Csesko PA (1988) Sexuality and multiple sclerosis. J Neurosci Nurs 20: 353–355

    PubMed  CAS  Google Scholar 

  • D'Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A (2006) Depression is the main determinant of quality of life in multiple sclerosis: A classification-regression (CART) study. Disabil Rehabil 28: 307–314

    Article  PubMed  Google Scholar 

  • Davids E, Hartwig U, Gastpar M (2004) Antipsychotic treatment of psychosis associated with multiple sclerosis. Prog Neuropsychopharmacol Biol Psychiatry 28: 743–744

    Article  PubMed  CAS  Google Scholar 

  • Davids Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C (1999) Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 11: 51–57

    Google Scholar 

  • Feinstein A, Feinstein K (2001) Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Disord 66: 193–198

    Article  PubMed  CAS  Google Scholar 

  • Feinstein A, O'Connor P, Feinstein K (2002) Multiple sclerosis, interferon beta-1b and depression. A prospective investigation. J Neurol 249: 815–820

    Article  PubMed  Google Scholar 

  • Feinstein A, Feinstein K, Gray T, O'Connor P (1997) Prevalence and neuro-behavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 54: 1116–1121

    PubMed  CAS  Google Scholar 

  • Feinstein A, O'Connor P, Gray T, Feinstein K (1999) Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex. Mult Scler 5: 69–73

    PubMed  CAS  Google Scholar 

  • Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP, Harboe E, Omdal R, Aarsland D (2005) Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatr Scand 112: 463–468

    Article  PubMed  CAS  Google Scholar 

  • Flax JW, Gray J, Herbert J (1991) Effect of fluoxetine on patients with multiple sclerosis. Am J Psychiatry 148: 1603

    PubMed  CAS  Google Scholar 

  • Folkerts H (1995) Electroconvulsive therapy in neurologic diseases. Nervenarzt 66: 241–251

    PubMed  CAS  Google Scholar 

  • Fowler CJ (1997) The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis. Baillieres Clin Neurol 6: 447–466

    PubMed  CAS  Google Scholar 

  • Fox RJ, Bethoux F, Goldman MD, Cohen JA (2006) Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease. Cleve Clin J Med 73: 91–102

    PubMed  Google Scholar 

  • Fredrikson S, Cheng Q, Jiang GX et al (2003) Elevated suicide risk among patients with multiple sclerosis in Sweden. Neuroepidemiology 22: 146–152

    Article  PubMed  CAS  Google Scholar 

  • Fruehwald S, Loeffler-Stastka H, Eher R, Saletu B, Baumhackl U (2001) Depression and quality of life in multiple sclerosis. Acta Neurol Scand 104: 257–261

    Article  PubMed  CAS  Google Scholar 

  • Galeazzi GM, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, Rigatelli M (2005) Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 26: 255–262

    Article  PubMed  CAS  Google Scholar 

  • Galetta SL, Markowitz C, Lee AG (2002) Immunomodulatory Agents for the Treatment of Relapsing Multiple Sclerosis. Arch Intern Med 162: 2161–2169

    Article  PubMed  CAS  Google Scholar 

  • Goldman Consensus Group New York (2005) The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 11: 328–337

    Article  Google Scholar 

  • Hart S, Fonareva I, Merluzzi N, Mohr DC (2005) Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Qual Life Res 14: 695–703

    Article  PubMed  Google Scholar 

  • Janssens AC, van Doorn PA, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ (2003) Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 108: 389–395

    Article  PubMed  CAS  Google Scholar 

  • Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Mood disorder and multiple sclerosis. Arch Neurol 44: 376–378

    PubMed  CAS  Google Scholar 

  • Jonsson A (2003) Disseminated sclerosis and sexuality. Ugeskr Laeger 165: 2642–2646

    PubMed  Google Scholar 

  • Koch T, Kralik D, Eastwood S (2002) Constructions of sexuality for women living with multiple sclerosis. J Adv Nurs 39: 137–145

    Article  PubMed  Google Scholar 

  • Leo RJ, Baer D (2005) Delirium associated with Baclofen withdrawal: A review of common presentations and a management strategies. Psychosomatics 46: 503–507

    Article  PubMed  CAS  Google Scholar 

  • Lerner DM, Stoudemire A, Rosenstein DL (1999) Neuropsychiatric toxicity associated with cytokine therapies. Psychosomatics 40: 428–435

    PubMed  CAS  Google Scholar 

  • Loftis JM, Hauser P (2004) The phenomenology and treatment of interferon-induced depression. J Affect Disord 82: 175–190

    Article  PubMed  CAS  Google Scholar 

  • MacAllister WS, Krupp LB (2005) Multiple sclerosis-related fatigue. Phys Med Rehabil Clin N Am 16: 483–502

    PubMed  Google Scholar 

  • Mattingly G, Baker K, Zorumski CF, Figiel GS (1992) Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients. J Neuropsychiatry Clin Neurosci 4: 145–151

    PubMed  CAS  Google Scholar 

  • Minden SL, Orav J, Reich P (1987) Depression in multiple sclerosis. Gen Hosp Psychiatry 9: 426–434

    Article  PubMed  CAS  Google Scholar 

  • Minden SL, Schiffer RB (1990) Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 47: 98–104

    PubMed  CAS  Google Scholar 

  • Minden SL (2000) Mood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol 6 (Suppl 2): 160–167

    Google Scholar 

  • Mohr DC, Classen C, Barrera M Jr (2004) The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychol Med 34: 533–541

    Article  PubMed  CAS  Google Scholar 

  • Nelson LD, Elder JT, Tehrani P, Groot J (2003) Measuring personality and emotional functioning in multiple sclerosis: a cautionary note. Arch Clin Neuropsychol 18: 419–429

    Article  PubMed  Google Scholar 

  • Patten SB, Metz LM (2001) Interferon beta-1 a and depression in relapsing–remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial. Mult Scler 7: 243–248

    PubMed  CAS  Google Scholar 

  • Patten SB, Beck CA, Williams JV, Barbui C, Metz LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology 61: 1524–1527

    PubMed  CAS  Google Scholar 

  • Rabins PV, Brooks BR, O'Donnell P, Pearlson GD, Moberg P, Jubelt B, Coyle P, Dalos N, Folstein MF (1986) Structural brain correlates of emotional disorder in multiple sclerosis. Brain 109 (Pt 4): 585–597

    Article  PubMed  Google Scholar 

  • Reischies FM, Baum K, Brau H, Hedde JP, Schwindt G (1988) Cerebral magnetic resonance imaging findings in multiple sclerosis. Relation to disturbance of affect, drive, and cognition. Arch Neurol 45: 1114–1116

    PubMed  CAS  Google Scholar 

  • Rodriguez Orozco AR (2004) Intravenous immunoglobulin and mitaxantrone stop progression of secondary progressive multiple sclerosis in a patient with interferon intolerance. Rev Alerg Mex 51: 124–126

    PubMed  Google Scholar 

  • Ron MA, Logsdail SJ (1989) Psychiatric morbidity in multiple sclerosis: a clinical and MRI study. Psychol Med 19: 887–895

    Article  PubMed  CAS  Google Scholar 

  • Sadovnick AD, Eisen K, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology 41: 1193–1196

    PubMed  CAS  Google Scholar 

  • Schiffer RB, Weitkamp LR, Wineman NM, Guttormsen S (1988) Multiple sclerosis and affective disorder. Family history, sex, and HLA-DR antigens. Arch Neurol 45: 1345–1348

    PubMed  CAS  Google Scholar 

  • Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147: 1493–1497

    PubMed  CAS  Google Scholar 

  • Schiffer RB, Wineman NM, Weitkamp LR (1986) Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatry 143: 94–95

    PubMed  CAS  Google Scholar 

  • Schmidt EZ, Hofmann P, Niederwieser G, Kapfhammer HP, Bonelli RM (2005) Sexuality in multiple sclerosis. J Neural Transm 112: 1201–1211

    Article  PubMed  CAS  Google Scholar 

  • Scott TF, Nussbaum P, McConnell H, Brill P (1995) Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale. Neurol Res 17: 421–422

    PubMed  CAS  Google Scholar 

  • Shafey H (1992) The effect of fluoxetine in depression associated with multiple sclerosis. Can J Psychiatry 37: 147–148

    PubMed  CAS  Google Scholar 

  • Siegert RJ, Abernethy DA (2005) Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 76: 469–475

    Article  PubMed  CAS  Google Scholar 

  • Solari A, Motta A, Mendozzi L, Aridon P, Bergamaschi R, Ghezzi A, Mancardi GL, Milanese C, Montanari E, Pucci E (2004) Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis. Neurol Sci 24: 375–383

    Article  PubMed  CAS  Google Scholar 

  • Stenager EN, Stenager E, Koch-Henriksen N et al (1992) Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 55: 542–545

    Article  PubMed  CAS  Google Scholar 

  • Sumelahti M-L, Tienari PJ, Wikstrom J et al (2002) Survival of multiple sclerosis in Finland between 1964 and 1993. Mult Scler 8: 350–355

    Article  PubMed  CAS  Google Scholar 

  • Surridge D (1969) An investigation into some psychiatric aspects of multiple sclerosis. Br J Psychiatry 115: 749–764

    Article  PubMed  CAS  Google Scholar 

  • Talley CL (2005) The emergence of multiple sclerosis, 1870–1950: a puzzle of historical epidemiology. Perspect Biol Med 48: 383–395

    Article  PubMed  Google Scholar 

  • Trzepacz PT, DiMartini A, Tringali R (1993) Psychopharmacological issues in organ transplantation. Part I: Pharmacokinetics in organ failure and psychiatric aspects of immunosuppressants and anti-infectious agents. Psychosomatics 34: 199–207

    PubMed  CAS  Google Scholar 

  • Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S (2000) Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J Clin Psychiatry 61: 261–267

    Article  PubMed  CAS  Google Scholar 

  • Young BK, Camicioli R, Ganzini L (1997) Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment. Drugs Aging 10: 367–383

    PubMed  CAS  Google Scholar 

  • Zephir H, De Seze J, Stojkovic T, Delisse B, Ferriby D, Cabaret M, Vermersch P (2003) Multiple sclerosis and depression: influence of interferon beta therapy. Mult Scler 9: 284–288

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie, Medizinische Universität Graz, Graz, Austria

    Peter Hofmann

Authors
  1. Eva Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernd Reininghaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt, E., Reininghaus, B. & Hofmann, P. Psychiatrische Auffälligkeiten bei Patienten mit Multipler Sklerose. Psychiatrie 2, 29–33 (2006). https://doi.org/10.1007/s11326-006-0016-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11326-006-0016-z

Schlüsselwörter

Keywords

Search

Navigation